Mission Bio Company
%20.jpg)
Leading precision medicine with the only single-cell multi-omics platform integrating genotype and phenotype
Investors
%20.jpg)
(INV)%20.jpg)
Connections from
Founded Date:
2012-01-01
Total Funding:
$110.1M
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Non-clinical Applications
Last Funding Type:
Series C
Investors Number:
12
Industry:
AI for Longevity
Headquarters:
Others
Estimated Revenue:
$10M to $50M